Navigation Links
Kensey Nash Investor Conference Schedule
Date:8/30/2011

EXTON, Pa., Aug. 30, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in September.

Kensey Nash will be participating at the Barrington Research Growth Conference 2011 in Chicago on Wednesday, September 7th, 2011.  The presentation materials will be available on the company's website (www.kenseynash.com) at 8:00 a.m. ET on Wednesday, September 7th, 2011.

Michael Celano, Kensey Nash's Chief Financial Officer, will deliver the Company's presentation, at the CL King's 9th Annual Best Ideas Conference at the Omni Berkshire Place Hotel in New York on Tuesday, September 13th, 2011 at 3:45 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.videonewswire.com/event.asp?id=81468.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 3:45 p.m. (ET) on Tuesday, September 13th, 2011.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York on Wednesday, September 21st, 2011 beginning at approximately at 9:00 a.m. (ET).  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Wednesday, September 21st, 2011.

Joseph W. Kaufmann will deliver the Company's presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27th, 2011 beginning approximately at 10:00 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.wsw.com/webcast/jeff62/knsy/.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 10:00 p.m. (ET) on Tuesday, September 27th, 2011.

About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit www.kenseynash.com.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results
2. Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2011 Earnings Release Date and Teleconference
3. Kensey Nash Announces New Unsecured Revolving Credit Facility
4. Kensey Nash to Present at the Jefferies 2011 Global Healthcare Conference
5. Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
6. Kensey Nash to Present at the Canaccord Genuity Musculoskeletal Conference
7. Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
8. Kensey Nash Announces a Manufacturing Agreement with and Minority Investment in Orteq Sports Medicine
9. Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
10. Kensey Nash to Present at Two Investor Conferences in November
11. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
Breaking Medicine News(10 mins):